Advertisement

NHH will be the best in Europe

– I praise NHH and aspirations for the contents of the action, says The Minister of Trade and Industry, Trond Giske.

Rector Jan I. Haaland, Norges Handelshøyskole (NHH)-Norwegian School of Economics and Business Administration stressed that NHH will be the best in Europe with a ten-year, triple action.

– I find it unnecessary that the Norwegian business schools compare themselves with their competitors in Swedish and Danish. Several Norwegian education institutions should set higher goals. It is clear that many Norwegian institutions are to utilize their resources better than they do today, said Trond Giske.

A major challenge

In a year. the industry committee worked in secrecy to get the action in place. The committee consists of Kreutzer, Secretary Elisabeth Berge of Petroleum and Energy, Helge Lund, Statoil's chief executive, Erik Mamelund, managing director of Ernst & Young, Katherine Trovik, division director of DnB NOR and Jens Ulltveit-Moe, CEO of UMOE, who are all former students of NHH.

– It is an exciting initiative. Trade and Industry Ministry is ready to finance the five-year investment program, "Crisis, restructuring and growth," "said Giske.

Kreutzer particularly wanted to present the action of the minister, because Giske had made a call for such an approach when he was Minister of Education (2000-2001)

About NHH

NHH was founded in 1936 and, together with its affiliated institutes SNF and AFF, constitutes the largest concentrated centre for research and study in the fields of economics and business administration in Norway.

NHH strives to be amongst the foremost in Europe in its fields, and EQUIS accreditation reinforces a strongly held belief that excellence in research is a prerequisite for excellence in teaching.

The school has over 2700 students and around 400 employees. The vast majority of the academic staff hold PhDs and the faculty includes the Nobel Prize winner Professor Finn E. Kydland.

A Continuing Challenge of Fake And Substandard Medicaments

Comments
- Advertisment -
Advertisement

Must Read